Cxcr3 targeting did not affect tumor growth in the spleen in the 5TGM1 and 5 T33 MM models, which is low due to NK cell surveillance [8] (Additional file 4: Fig. S3A and B). The gene discussed is CXCR3; the disease is Miyoshi myopathy.